CIBC World Market
UTHR icon

CIBC World Market’s United Therapeutics UTHR Stock Holding History

CIBC World Market’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$769K Buy
1,419
+399
+39% +$225K ﹤0.01% 1080
2026
Q1 		$605K Buy
+1,020
New +$508K ﹤0.01% 1063
2025
Q2 		– Sell
-15,499
Closed -$4.78M – 1478
2025
Q1 		$4.78M Sell
15,499
-9,819
-39% -$3.36M 0.01% 501
2024
Q4 		$8.93M Buy
25,318
+10,102
+66% +$3.71M 0.02% 368
2024
Q3 		$5.45M Buy
15,216
+10,158
+201% +$3.43M 0.01% 462
2024
Q2 		$1.61M Buy
+5,058
New +$1.34M ﹤0.01% 687
2022
Q3 		– Sell
-991
Closed -$234K – 1327
2022
Q2 		$234K Buy
+991
New +$201K ﹤0.01% 1099
2019
Q2 		– Sell
-15,201
Closed -$1.78M – 1234
2019
Q1 		$1.78M Sell
15,201
-82
-0.5% -$9.55K 0.01% 516
2018
Q4 		$1.66M Sell
15,283
-4,201
-22% -$487K 0.01% 487
2018
Q3 		$2.49M Sell
19,484
-1,905
-9% -$236K 0.01% 462
2018
Q2 		$2.42M Buy
21,389
+16,404
+329% +$1.8M 0.01% 430
2018
Q1 		$560K Buy
4,985
+3,549
+247% +$451K ﹤0.01% 812
2017
Q4 		$212K Sell
1,436
-2,313
-62% -$294K ﹤0.01% 752
2017
Q3 		$439K Sell
3,749
-17,149
-82% -$2.19M ﹤0.01% 562
2017
Q2 		$2.71M Buy
20,898
+14,447
+224% +$1.8M 0.01% 396
2017
Q1 		$873K Sell
6,451
-2,778
-30% -$421K ﹤0.01% 609
2016
Q4 		$1.32M Buy
9,229
+1,115
+14% +$142K ﹤0.01% 538
2016
Q3 		$958K Buy
8,114
+1,792
+28% +$215K ﹤0.01% 573
2016
Q2 		$670K Buy
6,322
+68
+1% +$7.58K ﹤0.01% 608
2016
Q1 		$697K Sell
6,254
-333
-5% -$42.1K ﹤0.01% 544
2015
Q4 		$1.03M Buy
+6,587
New +$959K 0.01% 480
2015
Q3 		– Sell
-14,655
Closed -$2.55M – 957
2015
Q2 		$2.55M Sell
14,655
-11,333
-44% -$2.04M 0.01% 295
2015
Q1 		$4.48M Buy
25,988
+23,580
+979% +$3.59M 0.02% 181
2014
Q4 		$312K Buy
2,408
+35
+1% +$4.51K ﹤0.01% 691
2014
Q3 		$305K Buy
+2,373
New +$245K ﹤0.01% 642

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

CIBC World Market's UTHR Position: Q2 2026 in Review

CIBC World Market increased its United Therapeutics (UTHR) stake by 39% in Q2 2026, buying an estimated $225K and bringing the position to 1,419 shares worth $769K. The position accounts for ﹤0.01% of the portfolio, ranked #1080.

CIBC World Market first reported a position in UTHR in Q3 2014 and has held it in 25 quarters since. The position peaked at $8.93M in Q4 2024. 881 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • CIBC World Market held 1,419 shares of United Therapeutics worth $769K as of Q2 2026.
  • CIBC World Market bought 399 United Therapeutics shares in Q2 2026, an estimated $225K.
  • United Therapeutics made up ﹤0.01% of CIBC World Market's portfolio in Q2 2026, its #1080 holding.
  • CIBC World Market first reported a position in United Therapeutics in Q3 2014 and has held it in 25 quarters since.
  • CIBC World Market's United Therapeutics position peaked at $8.93M in Q4 2024.
  • 881 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on CIBC World Market's 13F filing for Q2 2026, filed 13 Aug 2026.